
Nutriband Advances Abuse-Deterrent Drug Delivery with New Intellectual Property Protections
Nutriband secures critical trademark and international patents for its AVERSA transdermal pharmaceutical platform, positioning the company to address opioid abuse prevention and potentially capture a significant market opportunity.
Read full story





















